DLR German Aerospace Center   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Cologne Germany (1969)

Organization Overview

First Clinical Trial
2007
NCT01655953
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

DLR German Aerospace Center

Active Ingredients

Drugs in Phase 3 Trials (2)

morphine (1 trial)

triamcinolone (kenalog) (1 trial)

Drugs in Phase 2 Trials (2)

sacubitril (Entresto) (1 trial)

valsartan (diovan) (1 trial)

Drugs in Phase 1 Trials (2)

carbon dioxide (dry ice) (1 trial)

cd20 car-t cells (1 trial)

Drugs in Other Trials (6)

human milk (1 trial)

lupin protein (2 trials)

maltose (1 trial)

oxygen (1 trial)

sodium bicarbonate (3 trials)

whey protein (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 3)

Heart Failure (Phase 2)

Melanoma (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 11
  • # of Trial APIs: 12